European Companies Search Engine

8 EU fundings (€6,939,544): Deconstructing Intestinal Immune Tolerance … Bdl Year 2023 EU Research and Innovation programme "Horizon"

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Forschungsinstitut für molekulare Pathologie GmbH, Vienna, Austria.